Atenolol News and Research

RSS

Atenolol is a ß1 receptor specific antagonist, a drug belonging to the group of ß-blockers, a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and to treat and reduce the risk of heart complications following myocardial infarction (heart attack)

Beta blockers not as effective as other drugs that reduce high blood pressure in patients with hypertension

Beta blockers are not as effective as other drugs that reduce high blood pressure in patients with hypertension, concludes a meta-analysis published online by The Lancet.

18 Oct 2005

More doubt cast on benefit of beta blockers for high blood pressure

A comprehensive study has produced more evidence that a drug widely used to treat high blood pressure may not be the best option for many patients.

18 Oct 2005

Strokes and heart attacks can be prevented in people with high blood pressure

Most strokes and heart attacks in people with high blood pressure can be abolished by simply combining effective, modern blood pressure lowering drugs with treatment to reduce cholesterol.

6 Sep 2005

New blood pressure-lowering drugs reduce stroke risk by 50%

According to researchers the new types of blood pressure-lowering drugs are more effective in preventing strokes and heart attacks and save even more lives.

5 Sep 2005

Guidelines for treatment of essential tremor

Imagine not being able to hold a glass, tie your shoelaces or write a check. For people with the common movement disorder known as essential tremor, simple tasks requiring fine motor coordination become increasingly difficult, sometimes even impossible.

27 Jun 2005

Blood pressure treatment could cut risk of strokes and heart attacks

A new treatment strategy for hypertension can cut the risk of strokes by around 25 percent and coronary events by around 15 percent according to the preliminary results of a major international trial announced at the American College of Cardiology Late Breaking Clinical Trials II Meeting in Orlando today.

8 Mar 2005

Excellent news for the many people who suffer from high blood pressure

An international trial comparing blood-pressure lowering treatments has been stopped early due to the significantly better performance of one of the treatments in the trial.

8 Dec 2004

Atenolol beta-blocker may not be effective in reducing heart attacks

A study published in this weeks issue of THE LANCET suggest that atenolol - one of the most widely prescribed beta-blockers for reducing blood pressure - may not be effective in reducing heart attacks or death from cardiovascular causes.

5 Nov 2004

Anti-hypertensive drug clonidine before non-cardiac surgery reduces risk of complications due to inadequate blood flow to the heart

Patients with or at risk for heart disease who take the anti-hypertensive drug clonidine before non-cardiac surgery can significantly reduce the risk of complications and death due to inadequate blood flow to the heart, according to a study by UCSF researchers at the San Francisco Veterans Affairs Medical Center.

29 Jul 2004

Regular use of beta-agonist drugs for asthma could be endangering their patients

Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find.

17 Jun 2004